Resting-state EEG delta and alpha power predict response to cognitive behavioral therapy in depression: a Canadian biomarker integration network for depression study · Schwartzmann B, Quilty LC, Dhami P et al.

References

  1. JamesSLGlobal, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017Lancet20183921789185810.1016/S0140-6736(18)32279-730496104PMC6227754
  2. World Health Organization. Depression and other common mental disorders global health estimates (2017).
  3. World Health Organization. Depression. https://www.who.int/news-room/fact-sheets/detail/depression (2018).
  4. Gelenberg, A. J. et al. Practice guideline for the treatment of patients with major depressive disorder third edition work group on major depressive disorder (2010).
  5. KennedySLamRCohenNRavindranAClinical guidelines for the treatment of depressive disorders. IV. Medications and other biological treatmentsCan. J. Psychiatry200146Suppl 138S58S11441771
  6. ParikhSVCanadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: Section 2. Psychological treatmentsCan. J. Psychiatry20166152453910.1177/070674371665941827486150PMC4994791
  7. BeckATCognitive Therapy of Depression1979Guilford Press
  8. DriessenEHollonSDCognitive behavioral therapy for mood disorders: Efficacy, moderators and mediatorsPsychiatr. Clin. N. Am.20103353710.1016/j.psc.2010.04.005PMC293338120599132
  9. CuijpersPA meta-analysis of cognitive-behavioural therapy for adult depression, alone and in comparison with other treatmentsCan. J. Psychiatry20135837638510.1177/07067437130580070223870719
  10. ButlerACChapmanJEFormanEMBeckATThe empirical status of cognitive-behavioral therapy: A review of meta-analysesClin. Psychol. Rev.200626173110.1016/j.cpr.2005.07.00316199119
  11. HollonSPrevention of relapse following cognitive therapy vs medications in moderate to severe depressionArch. Gen. Psychiatry20056241742210.1001/archpsyc.62.4.41715809409
  12. RushAJAcute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D reportAm. J. Psychiatry20061631905191710.1176/ajp.2006.163.11.190517074942
  13. FricchioneGLCapacity building in global mental health: Professional trainingHarv. Rev. Psychiatry2012204710.3109/10673229.2012.65521122335182PMC3335114
  14. LiuJGoryakinYMaedaABrucknerTSchefflerRGlobal health workforce labor market projections for 2030Hum. Resour. Health201710.1186/s12960-017-0187-228159017PMC5291995
  15. ComerJSBarlowDHThe occasional case against broad dissemination and implementation: Retaining a role for specialty care in the delivery of psychological treatmentsAm. Psychol.201469110.1037/a003358223915401PMC4260460
  16. PayneKAMyhrGIncreasing access to cognitive-behavioural therapy (CBT) for the treatment of mental illness in canada: A research framework and call for actionHealthc. Policy20105e17321286263PMC2831741
  17. ShafranRMind the gap: Improving the dissemination of CBTBehav. Res. Ther.20094790290910.1016/j.brat.2009.07.00319664756
  18. ZhdanovAUse of machine learning for predicting escitalopram treatment outcome from electroencephalography recordings in adult patients with depressionJAMA Netw. Open20203e1918377e191837710.1001/jamanetworkopen.2019.1837731899530PMC6991244
  19. WuWAn electroencephalographic signature predicts antidepressant response in major depressionNat. Biotechnol.20203843944710.1038/s41587-019-0397-332042166PMC7145761
  20. AtluriSSelective modulation of brain network dynamics by seizure therapy in treatment-resistant depressionNeuroImage Clin.2018201176119010.1016/j.nicl.2018.10.01530388600PMC6214861
  21. BaskaranAThe comparative effectiveness of electroencephalographic indices in predicting response to escitalopram therapy in depression: A pilot studyJ. Affect. Disord.201810.1016/j.jad.2017.10.02829169123
  22. BaileyNWDifferentiating responders and non-responders to rTMS treatment for depression after one week using resting EEG connectivity measuresJ. Affect. Disord.2019242687910.1016/j.jad.2018.08.05830172227
  23. RajpurkarPEvaluation of a machine learning model based on pretreatment symptoms and electroencephalographic features to predict outcomes of antidepressant treatment in adults with depression: A prespecified secondary analysis of a randomized clinical trialJAMA Netw. Open20203e206653e20665310.1001/jamanetworkopen.2020.665332568399PMC7309440
  24. KnottVTelnerJLapierreYBrowneMHornEQuantitative EEG in the prediction of antidepressant response to imipramineJ. Affect. Disord.19963917518410.1016/0165-0327(96)00003-18856421
  25. KnottVMahoneyCKennedySEvansKPre-treatment EEG and it’s relationship to depression severity and paroxetine treatment outcomePharmacopsychiatry20003320120510.1055/s-2000-835611147926
  26. KnottVMahoneyCKennedySEvansKEEG correlates of acute and chronic paroxetine treatment in depressionJ. Affect. Disord.20026924124910.1016/S0165-0327(01)00308-112103473
  27. SackeimHAThe effects of electroconvulsive therapy on quantitative electroencephalograms: Relationship to clinical outcomeArch. Gen. Psychiatry19965381482410.1001/archpsyc.1996.018300900600098792758
  28. HillATModulation of functional network properties in major depressive disorder following electroconvulsive therapy (ECT): A resting-state EEG analysisSci. Rep.20201011310.1038/s41598-020-74103-y33051528PMC7555809
  29. IosifescuDVFrontal EEG predictors of treatment outcome in major depressive disorderEur. Neuropsychopharmacol.200910.1016/j.euroneuro.2009.06.00119574030
  30. SpronkDArnsMBarnettKJCooperNJGordonEAn investigation of EEG, genetic and cognitive markers of treatment response to antidepressant medication in patients with major depressive disorder: A pilot studyJ. Affect. Disord.201010.1016/j.jad.2010.06.02120619899
  31. PizzagalliDAnterior cingulate activity as a predictor of degree of treatment response in major depression: Evidence from brain electrical tomography analysisAm. J. Psychiatry200115840541510.1176/appi.ajp.158.3.40511229981
  32. KorbAHunterACookILeuchterARostral anterior cingulate cortex theta current density and response to antidepressants and placebo in major depressionClin. Neurophysiol.20091201313131910.1016/j.clinph.2009.05.00819539524PMC2710394
  33. BaileyNWResponders to rTMS for depression show increased fronto-midline theta and theta connectivity compared to non-respondersBrain Stimul.20181119020310.1016/j.brs.2017.10.01529128490
  34. JaworskaNExamining relations between alpha power as well as anterior cingulate cortex-localized theta activity and response to single or dual antidepressant pharmacotherapiesJ. Psychopharmacol.20142858759510.1177/026988111452386224557661
  35. BaresMChanges in QEEG prefrontal cordance as a predictor of response to antidepressants in patients with treatment resistant depressive disorder: A pilot studyJ. Psychiatr. Res.20074131932510.1016/j.jpsychires.2006.06.00516889798
  36. BaresMEarly reduction in prefrontal theta QEEG cordance value predicts response to venlafaxine treatment in patients with resistant depressive disorderEur. Psychiatry20082335035510.1016/j.eurpsy.2008.03.00118450430
  37. BaresMQEEG theta cordance in the prediction of treatment outcome to prefrontal repetitive transcranial magnetic stimulation or venlafaxine ER in patients with major depressive disorderClin. EEG Neurosci.201546738010.1177/155005941352044224711613
  38. BaresMNovakTVlcekPHejzlarMBrunovskyMEarly change of prefrontal theta cordance and occipital alpha asymmetry in the prediction of responses to antidepressantsInt. J. Psychophysiol.20191431810.1016/j.ijpsycho.2019.06.00631195067
  39. CookIAChanges in prefrontal activity characterize clinical response in SSRI nonresponders: A pilot studyJ. Psychiatr. Res.20053946146610.1016/j.jpsychires.2004.12.00215992554
  40. CookIAEarly changes in prefrontal activity characterize clinical responders to antidepressantsNeuropsychopharmacology20022712013110.1016/S0893-133X(02)00294-412062912
  41. BaresMThe change of prefrontal QEEG theta cordance as a predictor of response to bupropion treatment in patients who had failed to respond to previous antidepressant treatmentsEur. Neuropsychopharmacol.20102045946610.1016/j.euroneuro.2010.03.00720421161
  42. HunterAMChange in quantitative EEG theta cordance as a potential predictor of repetitive transcranial magnetic stimulation clinical outcome in major depressive disorderClin. EEG Neurosci.20184930631510.1177/155005941774621229224411
  43. BruderGEElectroencephalographic alpha measures predict therapeutic response to a selective serotonin reuptake inhibitor antidepressant: Pre- and post-treatment findingsBiol. Psychiatry2008631171117710.1016/j.biopsych.2007.10.00918061147PMC2652474
  44. BruderGEElectroencephalographic and perceptual asymmetry differences between responders and nonresponders to an SSRI antidepressant22Biol. Psychiatry20014941642510.1016/S0006-3223(00)01016-711274653
  45. UlrichGRenfordtEFrickKThe topographical distribution of alpha-activity in the resting EEG of endogenous-depressive in-patients with and without clinical response to pharmacotherapyPharmacopsychiatry19861927227310.1055/s-2007-1017230
  46. TenkeCECurrent source density measures of EEG alpha predict antidepressant treatment responseBiol. Psychiatry20117038810.1016/j.biopsych.2011.02.01621507383PMC3142299
  47. PellicciariMCDorsolateral prefrontal transcranial magnetic stimulation in patients with major depression locally affects alpha power of REM sleepFront. Hum. Neurosci.201310.3389/fnhum.2013.0043323935577PMC3731627
  48. ArnsMEEG alpha asymmetry as a gender-specific predictor of outcome to acute treatment with different antidepressant medications in the randomized iSPOT-D studyClin. Neurophysiol.201612750951910.1016/j.clinph.2015.05.03226189209
  49. MoscovitchDAFrontal EEG asymmetry and symptom response to cognitive behavioral therapy in patients with social anxiety disorderBiol. Psychol.20118737938510.1016/j.biopsycho.2011.04.00921571033
  50. KishonRLateralization for speech predicts therapeutic response to cognitive behavioral therapy for depressionPsychiatry Res.201522860661110.1016/j.psychres.2015.04.05426162656PMC4532556
  51. BruderGEHaggertyASiegleGJA quick behavioral dichotic word test is prognostic for clinical response to cognitive therapy for depression: A replication studyPsychiatry Res.2017248131910.1016/j.psychres.2016.12.01127992766PMC5444294
  52. BruderGEOutcome of cognitive-behavioral therapy for depression: Relation to hemispheric dominance for verbal processingJ. Abnorm. Psychol.199710613814410.1037/0021-843X.106.1.1389103725
  53. FranklinGCarsonAWelchKCognitive behavioural therapy for depression: Systematic review of imaging studiesActa Neuropsychiatr.201628617410.1017/neu.2015.4126122039
  54. MessinaISambinMPalmieriAVivianiRNeural correlates of psychotherapy in anxiety and depression: A meta-analysisPLoS One20138e7465710.1371/journal.pone.007465724040309PMC3770681
  55. RitcheyMDolcosFEddingtonKStraumanTCabezaRNeural correlates of emotional processing in depression: Changes with cognitive behavioral therapy and predictors of treatment responseJ. Psychiatr. Res.20114557758710.1016/j.jpsychires.2010.09.00720934190PMC3042483
  56. DhamiPAlterations in the neural correlates of affective inhibitory control following cognitive behavioral therapy for depression: A Canadian biomarker integration network for depression (CAN-BIND) studyJ. Affect. Disord. Rep.20221010041310.1016/j.jadr.2022.100413
  57. YangZCognitive behavioral therapy is associated with enhanced cognitive control network activity in major depression and posttraumatic stress disorderBiol. Psychiatry Cogn. Neurosci. Neuroimaging201833113192962806310.1016/j.bpsc.2017.12.006PMC5908226
  58. ArnalLHGiraudALCortical oscillations and sensory predictionsTrends Cogn. Sci.20121639039810.1016/j.tics.2012.05.00322682813
  59. HarperJMaloneSMBernatEMTheta and delta band activity explain N2 and P3 ERP component activity in a go/no-go taskClin. Neurophysiol.201412512413210.1016/j.clinph.2013.06.02523891195PMC4312493
  60. PradaLBarcelóFHerrmannCEsceraCEEG delta oscillations index inhibitory control of contextual novelty to both irrelevant distracters and relevant task-switch cuesPsychophysiology20145165867210.1111/psyp.1221024673586
  61. KnyazevGGMotivation, emotion, and their inhibitory control mirrored in brain oscillationsNeurosci. Biobehav. Rev.20073137739510.1016/j.neubiorev.2006.10.00417145079
  62. HarmonyTEEG delta activity: An indicator of attention to internal processing during performance of mental tasksInt. J. Psychophysiol.19962416117110.1016/S0167-8760(96)00053-08978441
  63. HarmonyTAlbaAMarroquínJLGonzález-FrankenbergerBTime-frequency-topographic analysis of induced power and synchrony of EEG signals during a Go/No-Go taskInt. J. Psychophysiol.20097191610.1016/j.ijpsycho.2008.07.02018804495
  64. HarmonyTThe functional significance of delta oscillations in cognitive processingFront. Integr. Neurosci.201378310.3389/fnint.2013.0008324367301PMC3851789
  65. BaşarEBaşar-ErogluCKarakaşSSchürmannMGamma, alpha, delta, and theta oscillations govern cognitive processesInt. J. Psychophysiol.20013924124810.1016/S0167-8760(00)00145-811163901
  66. KnyazevGGEEG delta oscillations as a correlate of basic homeostatic and motivational processesNeurosci. Biobehav. Rev.20123667769510.1016/j.neubiorev.2011.10.00222020231
  67. HusterRJEnriquez-GeppertSLavalleeCFFalkensteinMHerrmannCSElectroencephalography of response inhibition tasks: Functional networks and cognitive contributionsInt. J. Psychophysiol.20138721723310.1016/j.ijpsycho.2012.08.00122906815
  68. KaramacoskaDBarryRJSteinerGZResting state intrinsic EEG impacts on go stimulus-response processesPsychophysiology20175489490310.1111/psyp.1285128258583
  69. KaramacoskaDBarryRJSteinerGZColemanEPWilsonEJIntrinsic EEG and task-related changes in EEG affect Go/NoGo task performanceInt. J. Psychophysiol.2018125172810.1016/j.ijpsycho.2018.01.01529409782
  70. KaramacoskaDBarryRJSteinerGZUsing principal components analysis to examine resting state EEG in relation to task performancePsychophysiology201956e1332710.1111/psyp.1332730613986
  71. SargentKResting-state brain oscillations predict cognitive function in psychiatric disorders: A transdiagnostic machine learning approachNeuroImage Clin.20213010261710.1016/j.nicl.2021.10261733752077PMC7985402
  72. FaberPLDeactivation of the medial prefrontal cortex in experienced Zen meditatorsBrain Topogr.200820172
  73. TeiSMeditators and non-meditators: EEG source imaging during restingBrain Topogr.20092215816510.1007/s10548-009-0107-419653090
  74. StangeJPNeural markers of attention to aversive pictures predict response to cognitive behavioral therapy in anxiety and depressionBiol. Psychol.201712326927710.1016/j.biopsycho.2016.10.00927784617PMC5503152
  75. PeckhamADMcHughRKOttoMWA meta-analysis of the magnitude of biased attention in depressionDepress. Anxiety2010271135114210.1002/da.2075521049527
  76. LaufsHElectroencephalographic signatures of attentional and cognitive default modes in spontaneous brain activity fluctuations at restProc. Natl. Acad. Sci. U. S. A.2003100110531105810.1073/pnas.183163810012958209PMC196925
  77. NeuperCPfurtschellerGEvent-related dynamics of cortical rhythms: Frequency-specific features and functional correlatesInt. J. Psychophysiol.200143415810.1016/S0167-8760(01)00178-711742684
  78. BenedekMSchickelRJJaukEFinkANeubauerACAlpha power increases in right parietal cortex reflects focused internal attentionNeuropsychologia20145639340010.1016/j.neuropsychologia.2014.02.01024561034PMC3989020
  79. KlimeschWAlpha-band oscillations, attention, and controlled access to stored informationTrends Cogn. Sci.20121660661710.1016/j.tics.2012.10.00723141428PMC3507158
  80. FoxeJJSnyderACThe role of alpha-band brain oscillations as a sensory suppression mechanism during selective attentionFront. Psychol.2011215410.3389/fpsyg.2011.0015421779269PMC3132683
  81. PfurtschellerGStancákANeuperCEvent-related synchronization (ERS) in the alpha band—An electrophysiological correlate of cortical idling: A reviewInt. J. Psychophysiol.199624394610.1016/S0167-8760(96)00066-98978434
  82. O’Sullivan, M. et al. Comparison of electrode technologies for dry and portable EEG acquisition. Proc. - 2017 7th Int. Work. Adv. Sensors Interfaces, IWASI 2017 15–20 (2017). 10.1109/IWASI.2017.7974202
  83. HajareRKadamSComparative study analysis of practical EEG sensors in medical diagnosesGlob. Transit. Proc.2021246747510.1016/j.gltp.2021.08.009
  84. DelormeAMakeigSEEGLAB: An open source toolbox for analysis of single-trial EEG dynamics including independent component analysisJ. Neurosci. Methods200413492110.1016/j.jneumeth.2003.10.00915102499
  85. FarzanFStandardization of electroencephalography for multi-site, multi-platform and multi-investigator studies: Insights from the Canadian biomarker integration network in depressionSci. Rep.2017711110.1038/s41598-017-07613-x28785082PMC5547036
  86. de CheveignéAZapLine: A simple and effective method to remove power line artifactsbioRxiv201910.1101/78202931786167
  87. KlugMGramannKIdentifying key factors for improving ICA-based decomposition of EEG data in mobile and stationary experimentsEur. J. Neurosci.2021548406842010.1111/ejn.1499233012055
  88. Pion-TonachiniLKreutz-DelgadoKMakeigSThe ICLabel dataset of electroencephalographic (EEG) independent component (IC) featuresData Br.20192510410110.1016/j.dib.2019.104101PMC659540831294058
  89. TadelFBailletSMosherJCPantazisDLeahyRMBrainstorm: A user-friendly application for MEG/EEG analysisComput. Intell. Neurosci.201110.1155/2011/87971621584256PMC3090754
  90. GramfortAPapadopouloTOliviEClercMOpenMEEG: Opensource software for quasistatic bioelectromagneticsBiomed. Eng. Online2009812081920410.1186/1475-925X-9-45PMC2949879
  91. Pascual-MarquiRDStandardized low resolution brain electromagnetic tomography (sLORETA): Technical detailsMethods Find Exp. Clin. Pharmocol.20022451212575463
  92. DestrieuxCFischlBDaleAHalgrenEAutomatic parcellation of human cortical gyri and sulci using standard anatomical nomenclatureNeuroimage20105311510.1016/j.neuroimage.2010.06.01020547229PMC2937159
  93. MarisEOostenveldRNonparametric statistical testing of EEG- and MEG-dataJ. Neurosci. Methods200716417719010.1016/j.jneumeth.2007.03.02417517438
  94. GrossJGood practice for conducting and reporting MEG researchNeuroimage20136534936310.1016/j.neuroimage.2012.10.00123046981PMC3925794
  95. QuiltyLCThe structure of the Montgomery-Åsbergdepression rating scale over the courseof treatment for depressionInt. J. Methods Psychiatr. Res.20132217518410.1002/mpr.138824038301PMC6878407
  96. UherREarly and delayed onset of response to antidepressants in individual trajectories of change during treatment of major depression: A secondary analysis of data from the Genome-Based Therapeutic Drugs for Depression (GENDEP) studyJ. Clin. Psychiatry2011721478148410.4088/JCP.10m0641922127194
  97. WagnerSEarly improvement as a resilience signal predicting later remission to antidepressant treatment in patients with major depressive disorder: Systematic review and meta-analysisJ. Psychiatr. Res.2017949610610.1016/j.jpsychires.2017.07.00328697423
  98. SzegediAEarly improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: A meta-analysis including 6562 patientsJ. Clin. Psychiatry20097034435310.4088/JCP.07m0378019254516